WebSep 13, 2024 · ExThera Medical blood filter technology could play a crucial role in treating critically ill patients suffering from COVID-19. The Martinez, CA-based company is beginning a randomized clinical trial of the Seraph 100 Microbind Affinity Blood Filter (Seraph 100). The multicenter randomized controlled trial of the Seraph 100, will be studying the ... WebFeb 3, 2024 · ExThera Medical’s extracorporeal products have demonstrated life-saving capabilities in a wide range of critically ill patients suffering from sepsis and other severe …
Seraph 100 Blood Filter Shows Substantially Improved Survival Rates for ...
WebSep 20, 2024 · ExThera Medical’s Seraph ® 100 Microbind ® Affinity Blood Filter is a revolutionary hemoperfusion medical device that addresses unmet clinical needs in treating bloodstream infections and reducing pathogens. … WebJun 14, 2024 · ExThera Medical, the manufacturer of the Seraph 100 has obtained conditional approval from the US FDA to conduct the multicenter study on the treatment of critically ill patients with potentially ... hifi ldac
Fresenius Medical Care expands critical care offering with ExThera ...
WebMay 7, 2024 · On April 17th, the US Food and Drug Administration awarded ExThera an Emergency Use Authorisation to use the device in treating Covid-19 patients. Gorta said its partnership with ExThera aimed... WebJan 7, 2024 · Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure, will offer the Seraph 100 Microbind Affinity Blood Filter from ExThera Medical Corporation in several European countries as of now. Both companies have signed a co-marketing and distribution agreement, effective in January … WebSee ExThera Medical funding rounds, investors, investments, exits and more. Evaluate their financials based on ExThera Medical's post-money valuation and revenue. … hifiknights